Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by Amalgamated Bank

Amalgamated Bank increased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONGet Rating) by 2.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 50,315 shares of the biotechnology company’s stock after acquiring an additional 1,399 shares during the period. Amalgamated Bank’s holdings in Axon Enterprise were worth $6,930,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. American Trust acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at about $413,000. Defender Capital LLC. lifted its stake in Axon Enterprise by 4.1% in the 1st quarter. Defender Capital LLC. now owns 107,810 shares of the biotechnology company’s stock valued at $15,022,000 after buying an additional 4,230 shares in the last quarter. Capital International Sarl purchased a new position in Axon Enterprise in the 1st quarter valued at about $2,376,000. Golden State Wealth Management LLC lifted its stake in Axon Enterprise by 4.0% in the 1st quarter. Golden State Wealth Management LLC now owns 6,172 shares of the biotechnology company’s stock valued at $850,000 after buying an additional 240 shares in the last quarter. Finally, Capital International Ltd. CA purchased a new position in Axon Enterprise in the 1st quarter valued at about $1,394,000. 78.44% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 1.5 %

AXON stock opened at $118.34 on Monday. The firm has a market cap of $8.41 billion, a PE ratio of 60.69 and a beta of 0.64. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.35 and a current ratio of 2.70. The firm’s 50 day moving average price is $119.53 and its 200-day moving average price is $103.82. Axon Enterprise, Inc. has a one year low of $82.49 and a one year high of $209.00.

Axon Enterprise (NASDAQ:AXONGet Rating) last released its quarterly earnings results on Tuesday, August 9th. The biotechnology company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.09 by $0.62. Axon Enterprise had a net margin of 14.20% and a return on equity of 12.57%. The firm had revenue of $285.61 million for the quarter, compared to analyst estimates of $258.96 million. During the same quarter in the previous year, the company earned ($0.72) EPS. The business’s revenue for the quarter was up 30.5% compared to the same quarter last year. On average, equities research analysts anticipate that Axon Enterprise, Inc. will post 0.39 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Barclays assumed coverage on shares of Axon Enterprise in a research note on Thursday. They issued an “overweight” rating and a $147.00 price target on the stock. Morgan Stanley lowered shares of Axon Enterprise from an “overweight” rating to an “equal weight” rating and set a $120.00 price target on the stock. in a research note on Monday, May 23rd. Robert W. Baird raised their price target on shares of Axon Enterprise from $130.00 to $150.00 and gave the company an “outperform” rating in a research note on Thursday, August 18th. Credit Suisse Group raised their target price on shares of Axon Enterprise from $134.00 to $142.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 10th. Finally, JMP Securities reissued a “buy” rating and issued a $195.00 target price on shares of Axon Enterprise in a research note on Wednesday, June 1st. Two analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $164.22.

Axon Enterprise Company Profile

(Get Rating)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONGet Rating).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.